logo
Rothschild & Co names Aalok Shah as new India head

Rothschild & Co names Aalok Shah as new India head

Mint3 days ago

Mumbai: Rothschild & Co has appointed Aalok Shah as the head of global advisory for India, succeeding Chandresh Ruparel, the firm said in a statement on Wednesday.
Shah, who joined Rothschild in 2006, was named co-head of its India business last year. He has worked extensively across Mumbai and London. In his new role, he will lead the next phase for growth for Rothschild & Co's advisory business in India, the company said.
Ruparel will transition to the role of senior advisor after more than two decades of building Rothschild's India franchise. He will provide strategic counsel, mentor senior bankers, and continue to support key corporate client relationships, it added.
Rothschild & Co, a family-controlled and independent firm, employs around 4,600 people across 40 countries. Its services span global advisory, wealth and asset management, and Five Arrows—its alternative assets division. The global advisory arm provides M&A and financing advice to large and mid-sized companies, private equity firms, entrepreneurs, families, and governments.
In India, the Paris-headquartered firm has recently expanded its offerings to include equity capital markets (ECM) advisory. Its services now cover equity fundraising, strategic capital, debt advisory, and restructuring across sectors such as automotive, consumer and retail, energy and power, financial institutions, healthcare, industrials, life sciences, technology/media/telecom, and transport and infrastructure.
In healthcare, Rothschild recently advised TPG and Evercare on the sale of a controlling stake in Care Hospitals to Blackstone in 2023, advised on the sale of a majority stake in Ideal Cures to Colorcon the same year, and on the sale of Oaknet Healthcare to Eris Lifesciences in 2022.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sunjay Kapur: Billionaire who generated a buzz both in life and death
Sunjay Kapur: Billionaire who generated a buzz both in life and death

New Indian Express

time3 hours ago

  • New Indian Express

Sunjay Kapur: Billionaire who generated a buzz both in life and death

For the Daily Mirror, it was Prince William's pal who was no more. For many news outlets in India, Sunjay Kapur's was the passing away of actresses Karisma Kapoor and Priya Sachdev's husband. For business journalists, it was the death of a tycoon worth $1.3 billion and whose company supplied key components to Tesla and Jaguar Land Rover. Put simply, 53-year-old Sunjay, an American national born in Michigan in 1971 to a Punjabi family, had done enough and more to grab headlines before he collapsed unexpectedly on a polo ground in London on June 12, 2025. His death would go on to be made all the more dramatic by the fact that he appeared to have allegedly swallowed a bee moments before his death. This triggered speculation that the bee had flown into his mouth and stung him, triggering a heart attack. Or was it instead a plain cardiac arrest that claimed his life? A highly sought-after post-mortem, which will provide clarity on the cause of the death, is awaited. Auto component tycoon whom even Elon Musk needed Before his untimely death, Kapur was best known for his leadership at Sona BLW Precision Forgings (Sona Comstar). Sunjay took over the business after the death of his father, Surinder Kapur, the founder of the Gurgaon-headquartered Sona Group in 2015. Under his guidance, the company expanded its overseas presence and grew into a global supplier for the world's biggest automakers. Even Elon Musk came calling as we had mentioned before. Sona has 11 manufacturing and assembly plants spread across India, China, Mexico, and the USA. India serves as the manufacturing hub, while the rest are the final assembly and finishing plants. Kapur, who became the managing director of the company in 2015, spearheaded the expansion into Electric Vehicle (EV) components. In ten years, Sona Comstar has grown into one of world's largest producers of EV traction motor components by volume. In 2021, he led the company through a successful IPO. Sona, under his leadership, also went on to acquire a 54% stake in Serbia-based Novelic for 40.5 million euro and took over Railway Equipment Division from Escorts Kubota. Kapur also served as the President of the Automotive Component Manufacturers Association of India (ACMA) and played a key role in steering the Indian auto component industry after the COVID-19 pandemic. While Kapur was hailed as a visionary for driving Sona Comstar's shift toward EV technology, his leadership faced turbulence. Reports cited clashes with board members over strategy, with some stakeholders criticising his aggressive expansion approach. Tumultuous personal life But what grabbed the headlines here in India was Kapur's tumultuous personal life, particularly his high-profile divorce from actress Karisma Kapoor. The businessman was married three times. He first got into the public eye after tying the knot with Hindi film actress Karisma Kapoor in 2003 in a star-studded ceremony. The couple had two children, Samaira and Kiaan, before they filed for mutual divorce in 2016. Their separation turned into a sour legal battle, with allegations of infidelity, financial disputes, and custody fights. The hostility between the two families was such that Karisma's father and actor Randhir Kapoor called Sunjay Kapur "a third-class man" and stressed he never wanted his daughter to marry him. Before Karisma, Sunjay was married to designer Nandita Mahtani. In 2017, he married former model and actress Priya Sachdev. This marriage also grabbed eyeballs as Priya was earlier married to Vikram Chatwal, the son of Sant Singh Chatwal, an Indian American businessman and founder of the Dream Hotel Group. With Priya, Sunjay has a son, Azarias, and he had also adopted her daughter, Safira Chatwal, from her previous marriage. In the midst of all this, Kapur also found the energy to indulge his passion for polo—right till the end. He was a known figure in the UK's elite polo circles, and played with Prince William and other members of the British royal family. It was during a polo appearance in the Cartier Trophy semi-finals at the Guards Polo Club in England that Sunjay reportedly said "I've swallowed something" before falling one last time. His "tireless enthusiasm", as his polo friends put it, will be missed on the grounds and beyond.

Granules arm gets U.S. FDA observation resolved
Granules arm gets U.S. FDA observation resolved

The Hindu

time6 hours ago

  • The Hindu

Granules arm gets U.S. FDA observation resolved

Generic drugmaker Granules India on Saturday said subsidiary Granules Pharmaceuticals Inc. addressed and resolved a U.S. Food and Drug Administration observation during the same inspection when it was issued by the regulator. The U.S. FDA had completed a pre-approval inspection (PAI) for a first to file controlled substance ANDA (abbreviated new drug application) at the facility of Granules Pharmaceuticals Inc. in Chantilly, Virginia, USA from June 23-27 with one Form 483 observation. The subsidiary 'addressed and resolved the observation during the inspection,' the Hyderabad-headquartered parent company said in a filing. Last week the U.S. FDA had issued an observation to Granules India's active pharmaceutical ingredients (API) manufacturing facility in Bonthapally, Hyderabad, which is one of the world's largest single-site paracetamol API manufacturing plants by volume.

Aurobindo Pharma arm recalling 48,000 vials of Gentamicin Injection in U.S.
Aurobindo Pharma arm recalling 48,000 vials of Gentamicin Injection in U.S.

The Hindu

time6 hours ago

  • The Hindu

Aurobindo Pharma arm recalling 48,000 vials of Gentamicin Injection in U.S.

Eugia US LLC, a step down subsidiary of Hyderabad-headquartered generic drugmaker Aurobindo Pharma, is recalling 48,000 vials of Gentamicin Injection paediatric doses from the U.S. The Gentamicin Injection, USP, (paediatric), 20 mg per 2 mL, 2 mL Single-Dose Vial are manufactured in India, the latest enforcement report of the U.S Food and Drug Administration showed. The injections are being recalled as a result of failed stability specifications - out of specification results for the colour absorbance test during 12 month sample analysis, the regulator said. It is a voluntary recall and initiated by the company on May 29. Gentamicin is an antibiotic and used to treat bacterial infections.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store